Julie Brown, chief operating and financial officer of Burberry Group Plc, is to join GlaxoSmithKline Plc as CFO in 2023, succeeding Iain Mackay who has decided to retire. Ms Brown will join GSK in April and start her new job as CFO and executive director on 1 May. She brings with her executive experience in both the pharma and medical technology sectors. Her previous employers include Smith & Nephew Plc, where she was CFO, and AstraZeneca Plc, where she was interim group CFO. Ms Brown is a Fellow of the Institute of Chartered Accountancy in England and Wales.
GlaxoSmithKline announced the appointment on 26 September 2022.
Copyright 2022 Evernow Publishing Ltd